Biogen Ma Drug Patent Portfolio
Biogen Ma owns 1 orange book drug protected by 3 US patents Given below is the list of Biogen Ma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10385341 | Compositions for modulating SOD-1 expression | 01 Apr, 2035 | Active |
| US10669546 | Compositions for modulating SOD-1 expression | 01 Apr, 2035 | Active |
| US10968453 | Compositions for modulating SOD-1 expression | 01 Apr, 2035 | Active |
Latest Legal Activities on Biogen Ma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Biogen Ma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 22 May, 2024 | US10385341 |
| Second letter to regulating agency to determine regulatory review period | 22 May, 2024 | US10968453 |
| Second letter to regulating agency to determine regulatory review period | 22 May, 2024 | US10669546 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US10669546 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US10385341 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US10968453 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Feb, 2024 | US10669546 |
|
Email Notification
Critical
| 01 Feb, 2024 | US10669546 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Feb, 2024 | US10968453 |
|
Email Notification
Critical
| 01 Feb, 2024 | US10968453 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 31 Jan, 2024 | US10385341 |
|
Email Notification
Critical
| 31 Jan, 2024 | US10385341 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 21 Dec, 2023 | US10385341 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 21 Dec, 2023 | US10669546 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 21 Dec, 2023 | US10968453 |
Biogen Ma's Family Patents
Biogen Ma Drug List
Given below is the complete list of Biogen Ma's drugs and the patents protecting them.
1. Qalsody
Qalsody is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10385341 | Compositions for modulating SOD-1 expression |
01 Apr, 2035
(9 years from now)
| Active |
| US10669546 | Compositions for modulating SOD-1 expression |
01 Apr, 2035
(9 years from now)
| Active |
| US10968453 | Compositions for modulating SOD-1 expression |
01 Apr, 2035
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qalsody's drug page